Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Statins may affect prostate cancer microenvironment

Allott E et al. AUA 2018 (annual meeting of the American Urological Association), Abstract MP21-01.

Key clinical point: Researchers hope that genetic analyses could eventually point to prostate cancer patients who might benefit from statin use.

Major finding: Long-term statin users had lower odds of having a pTEN-null tumor (hazard ratio, 0.42), which is associated with worse outcomes.

Study details: Retrospective analysis of 5,792 diagnoses of prostate cancer among 44,076 men.

Disclosures: The study was funded by the Irish Cancer Society, the John Fitzpatrick Fellowship, and the National Cancer Institute. Dr. Allott reported no relevant financial relationships.

Source: Allott E et al. AUA 2018, Abstract MP21-01.

Citation:

Allott E et al. AUA 2018 (annual meeting of the American Urological Association), Abstract MP21-01.

This Week's Must Reads

New MOC pathway developed by ABIM, ASCO, Alternative to focus on oncology expertise

Survey indicates opioid prescriptions have decreased , Physicians' progress to reverse the nation's opioid epidemic. American Medical Association.

Oncologists sue over Medicare drug pay cut, Community Oncology Alliance v. Office of Management and Budget et al. ​

Gender disparity found in oncology research funding, Zhou CD et al. BMJ Open. 2018 Apr 30. doi: 10.1136/bmjopen-2017-018625

Trump administration rejects ACA lawsuit, Texas v. The United States centers on the individual mandate

Must Reads in Genitourinary Cancer

Access to care linked to better outcomes in black men with prostate cancer, Halabi et al, George et al. ASCO 2018 (annual meeting of the American Society of Clinical Oncology) Abstracts LBA5005 and LBA5009.

Statins may affect prostate cancer microenvironment, Allott E et al. AUA 2018 (annual meeting of the American Urological Association), Abstract MP21-01.

Prostate cancer risks higher in smokers, Foerster B et al. JAMA Oncol. 2018 May 24. doi: 10.1001/jamaoncol.2018.1071.

Prostate cancer: Docetaxel prednisone response better in black men, Halabi et al, George et al. ASCO 2018 Abstracts LBA5005 and LBA5009.

Cochrane On Bisphosphonates for Prostate Cancer, Cochrane; 2017 Dec 26; Macherey, Monsef, et al